Mallinckrodt to Buy Immunotherapy Firm Therakos

13.08.2015 - Irish drugmaker Mallinckrodt said it plans to acquire US immunotherapy company Therakos for $1.33 billion from American private equity investor Gores Group. The deal is planned to...